- Trials with a EudraCT protocol (105)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
105 result(s) found for: Dna Marker.
Displaying page 1 of 6.
EudraCT Number: 2009-017340-14 | Sponsor Protocol Number: RHMCAN0700 | Start Date*: 2011-07-26 |
Sponsor Name:University Hospital Southampton NHS Foundation Trust | ||
Full Title: WT1 Immunity via DNA fusion Gene Vaccination in Haematological Malignancies by intramuscular injection followed by intramuscular electroporation. | ||
Medical condition: Chronic myeloid Leukemia and acute myeloid leukemia in cytogentic remission | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-000106-37 | Sponsor Protocol Number: 37.07.-92906 | Start Date*: 2008-08-28 | |||||||||||
Sponsor Name:Klinik für Dermatologie und Allergologie der RUB, St. Josef Hospital | |||||||||||||
Full Title: Studies on the combined treatment using etanercept and ultraviolet B for patients with moderate to severe psoriasis vulgaris | |||||||||||||
Medical condition: Psoriasis vulgaris (Plaque-Typ) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001515-22 | Sponsor Protocol Number: S54226 | Start Date*: 2012-05-16 |
Sponsor Name:Katholieke Universiteit Leuven | ||
Full Title: Cytomegalovirus infection and the influenza vaccination response in older persons | ||
Medical condition: Humoral and cellular immune response after vaccination in older people | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001742-13 | Sponsor Protocol Number: 06_RADIO_56 | Start Date*: 2006-10-04 |
Sponsor Name:Christie Hospital NHS Trust | ||
Full Title: Locally Advanced Pancreatic Cancer: Phase II study of cetuximab and 3-D conformal image-guided radiotherapy (PACER Study) | ||
Medical condition: Adenocarcinoma of the pancreas which is locally advanced/inoperable | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-005634-59 | Sponsor Protocol Number: TEA-001 | Start Date*: 2015-04-29 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: Toll-like receptor 9 enhancement of antiviral immunity in chronic HIV-1 infection: a phase 1b/2a trial (TEACH) | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001788-19 | Sponsor Protocol Number: ECS1479/2017 | Start Date*: 2018-08-24 |
Sponsor Name:Medical University Vienna | ||
Full Title: Metformin therapy to prohibit progression in patients with abdominal aortic aneurysm | ||
Medical condition: Abdominal aortic aneurysm | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004874-42 | Sponsor Protocol Number: TRAFO001 | Start Date*: 2009-02-06 | |||||||||||
Sponsor Name:Institut für Frauengesundheit GmbH | |||||||||||||
Full Title: Evaluation of predictive Factors for the Effectivity of Aromatase Inhibitor Therapy - Offene, prospektive, multizentrische Phase IV-Studie zur Untersuchung des Einflusses von pharmakogenetischen M... | |||||||||||||
Medical condition: The study examines the influence of pharmacogenetic markers on the efficacy and side effects in postmenopausal, steroid hormone positive breast cancer patients, who are treated with Letrozol. The p... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003689-41 | Sponsor Protocol Number: CRAD001YGB11 | Start Date*: 2012-11-19 |
Sponsor Name:Novartis Pharmaceuticals UK Ltd | ||
Full Title: A Phase IV multicentre, open label study of postmenopausal women with oestrogen receptor positive locally advanced or metastatic breast cancer treated with everolimus (RAD001) in combination with e... | ||
Medical condition: oestrogen receptor positive breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014694-40 | Sponsor Protocol Number: SSAT033 | Start Date*: 2009-11-11 |
Sponsor Name: | ||
Full Title: A pilot evaluation of the pharmacokinetics, efficacy and safety of switching from efavirenz to maraviroc administered at 600mg then 300mg twice-daily in patients suppressed on an efavirenz-containi... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000685-42 | Sponsor Protocol Number: 2DR-study | Start Date*: 2020-04-30 |
Sponsor Name:Ghent University Hospital | ||
Full Title: Virological and immunological assessment in HIV positive participants on 2DR versus 3DR in a prospective randomized controlled switch trial. | ||
Medical condition: human immunodeficiency viruses (HIV) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002169-16 | Sponsor Protocol Number: ERASE-CRC | Start Date*: 2022-06-10 | ||||||||||||||||
Sponsor Name:Fondazione GONO | ||||||||||||||||||
Full Title: EXPLOITING CIRCULATING TUMOUR DNA TO INTENSIFY THE POST-OPERATIVE TREATMENT OF STAGE III AND HIGH-RISK STAGE II RESECTED COLON CANCER PATIENTS WITH ADJUVANT FOLFOXIRI AND/OR POST-ADJUVANT TRIFLURID... | ||||||||||||||||||
Medical condition: STAGE III AND HIGH-RISK STAGE II RESECTED COLON CANCER PATIENTS. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001923-30 | Sponsor Protocol Number: TN-20 | Start Date*: 2016-09-26 | |||||||||||
Sponsor Name:TRIALNET COORDINATING CENTER AT THE UNIVERSITY OF SOUTH FLORIDA | |||||||||||||
Full Title: Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus | |||||||||||||
Medical condition: Type 1 Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003296-60 | Sponsor Protocol Number: Oxidise | Start Date*: 2018-04-09 |
Sponsor Name:University Hospital Tuebingen | ||
Full Title: Empagliflozin effect on glucose toxicity in type 2 diabetes patients - a randomized, open-label, controlled, parallel group, exploratory study | ||
Medical condition: Patients with T2DM aged 40 to 70 years (including) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-002784-18 | Sponsor Protocol Number: 13005 | Start Date*: 2018-07-24 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: Safety and efficacy of Tofacitinib in ameliorating ischaemia reperfusion injury and allograft pancreatitis in solid organ transplantation – a pilot study | |||||||||||||
Medical condition: Ischaemia reperfusion injury and allograft pancreatitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001587-38 | Sponsor Protocol Number: OPTIPRIME | Start Date*: 2019-08-05 |
Sponsor Name:Fédération Francophone de Cancérologie Digestive | ||
Full Title: A phase II study evaluating FOLFOX + panitumumab according to a "stop and go" strategy with a reintroduction loop after progression on fluoropyrimidine as maintenance treatment, as the first line i... | ||
Medical condition: metastatic colorectal adenocarcinoma without a RAS mutation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000622-22 | Sponsor Protocol Number: 73763989HPB2001 | Start Date*: 2019-08-20 | |||||||||||
Sponsor Name:Janssen Sciences Ireland UC | |||||||||||||
Full Title: A Phase 2b, Multicenter, Double-blind, Active-controlled, Randomized Study to Investigate the Efficacy and Safety of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for th... | |||||||||||||
Medical condition: Chronic Hepatitis B Virus Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) DE (Completed) CZ (Completed) ES (Completed) BE (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005497-28 | Sponsor Protocol Number: PedMic | Start Date*: 2013-09-27 |
Sponsor Name:Erasmus MC - Sophia | ||
Full Title: Pediatric Microdosing: elucidating age-related changes in oral absorption | ||
Medical condition: Age-related changes in intestinal drug metabolism in children | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000601-11 | Sponsor Protocol Number: Soratace-1 | Start Date*: 2008-03-06 |
Sponsor Name:Medizinische Universität Wien Univ. Klinik f. Innere Med. III, Abt. f. Gastroenterologie/Hepatologie | ||
Full Title: SORATACE: Sorafenib (Nexavar®) as inhibitor of collateral tumor vessel growth during transarterial chemoembolisation (TACE) for Hepatocellular Carcinoma (HCC)- a pilot trial to evaluate safety and ... | ||
Medical condition: hepatocellular carcinoma patients undergoing transarterial chemoembolisation (TACE) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-023103-94 | Sponsor Protocol Number: 002:CD40L | Start Date*: 2011-07-04 |
Sponsor Name:Uppsala University | ||
Full Title: PHASE I/IIa AdCD40L IMMUNOGENE THERAPY FOR MALIGNANT MELANOMA PATIENTS WITH DISSEMINATED DISEASE | ||
Medical condition: malignant melanoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004524-41 | Sponsor Protocol Number: KFE-2022 | Start Date*: 2020-12-03 | ||||||||||||||||
Sponsor Name:Aarhus University Hospital/Karen-Lise Garm Spindler | ||||||||||||||||||
Full Title: OPTIMISE: OPTIMIzation of treatment SElection and follow up in oligometastatic colorectal cancer - a ctDNA guided phase II randomized approach | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.